MAPT and Alzheimer disease: Building on this framework, our previous research12 demonstrated that longer A+ chronicity was associated with increased tau positron emission tomography (PET) accumulation and accelerated cognitive decline on a preclinical AD composite in cognitively unimpaired (CU) individuals at baseline.